India's largest pharma company not need any explanation for the investors. After the take over of Daiichi Sankyo ,initial hiccups on integration of management is almost over .Under the new leadership,company is expected to perform well going forward.In the latest qtr ,
Ranbaxy's domestic sales posted very good performance but it partially offset by the not so good sales outside.Company is expected better performance in near future due to the beginning of the supply of Nexium API and formulations.In an effort to strengthen its local sale,company recently recruited more than 1000 field staff.All these efforts under the new management is expected to help the company to capture the past glory. Investors can add Ranbaxy in their portfolio for long term gains.Considering the volatility in the market ,it is better to buy in small lots.CMP is Rs.570/-
dear valuepick
ReplyDeletewld appreciate yourviews on ramsarup industries
Sorry not tracking Ramsarup
ReplyDeleteDear valupickji,
ReplyDeleteThanks for boosting confidence in this share, I am holding this share @ 430. Hope do well in future.
Regards,
Mahendra
Hi Sir,
ReplyDeleteCould you please update on DHP India, i have small holding of higher level when you recommended and now 26 it touched today. Please update
Hi an
ReplyDeleteSince the company is not performing in last few qtrs and not willing to share any updates on its working and future plans ,it is better to book loss and shift to some other cos.
Dear Valuepick,
ReplyDeleteTechnofab engineering corrected sharply.still it is a buy only or is there something negative about this share?
Regards,
Joshy
Hi,
ReplyDeleteI have holding in De Nora based on your recommendation. Please let me know the prospects. Can it be still averaged?
Regards
Srs
Dear Friends
ReplyDeleteshort term price movements are always depends on market sentiments.Try to accept it as a part of market